O
O
I
R
Trending Research
Journal Rankings
About
New:
Think Tank Rankings 2025
Field of Research:
Clinical Medicine
»
Category:
Oncology
Agricultural Sciences
Arts & Humanities
Biology & Biochemistry
Chemistry
Clinical Medicine
Computer Science
Economics & Business
Engineering
Environment and Ecology
Geosciences
History & Archaeology
Literature & Language
Materials Science
Mathematics
Multidisciplinary
Philosophy & Religion
Physics
Plant & Animal Science
Psychiatry and Psychology
Social Sciences
Visual & Performing Arts
Allergy
Andrology
Anesthesiology
Audiology & Speech-Language Pathology
Behavioral Sciences
Cardiac & Cardiovascular Systems
Clinical Neurology
Critical Care Medicine
Dentistry, Oral Surgery & Medicine
Dermatology
Emergency Medicine
Endocrinology & Metabolism
Engineering, Biomedical
Gastroenterology & Hepatology
Genetics & Heredity
Geriatrics & Gerontology
Health Care Sciences & Services
Health Policy & Services
Hematology
Immunology
Infectious Diseases
Integrative & Complementary Medicine
Materials Science, Biomaterials
Medical Ethics
Medical Informatics
Medical Laboratory Technology
Medicine, General & Internal
Medicine, Legal
Medicine, Research & Experimental
Neuroimaging
Neurosciences
Nursing
Nutrition & Dietetics
Obstetrics & Gynecology
Oncology
Ophthalmology
Orthopedics
Otorhinolaryngology
Pathology
Pediatrics
Peripheral Vascular Disease
Pharmacology & Pharmacy
Primary Health Care
Psychiatry
Psychology, Clinical
Public, Environmental & Occupational Health
Radiology, Nuclear Medicine & Medical Imaging
Rehabilitation
Reproductive Biology
Respiratory System
Rheumatology
Sport Sciences
Substance Abuse
Surgery
Toxicology
Transplantation
Tropical Medicine
Urology & Nephrology
Virology
Oncology
Trending Papers
(Powered by
Altmetrics
)
7 days
14 days
30 days
Sucralose consumption ablates cancer immunotherapy response through microbiome disruption.
Cancer Discovery
2025-08-02
Whole body MRI by MY-RADS for imaging response assessment in multiple myeloma
Blood Cancer Journal
2025-08-07
Tumor Treating Fields With Gemcitabine and Nab-Paclitaxel for Locally Advanced Pancreatic Adenocarcinoma: Randomized, Open-Label, Pivotal Phase III PA
Journal of Clinical Oncology
2025-08-04
Grade Group 1 Prostate Cancer Outcome by Biopsy Grade and Risk Group
JAMA Oncology
2025-08-02
Azacitidine, Venetoclax, and Revumenib for Newly Diagnosed NPM1 -Mutated or KMT2A -Rearranged AML
Journal of Clinical Oncology
2025-08-10
Pasritamig, a First-in-Class, Bispecific T-Cell Engager Targeting Human Kallikrein 2, in Metastatic Castration-Resistant Prostate Cancer: A Phase I St
Journal of Clinical Oncology
2025-08-04
Extrachromosomal DNA-Driven Oncogene Dosage Heterogeneity Promotes Rapid Adaptation to Therapy in MYCN-Amplified Cancers
Cancer Discovery
2025-08-13
Zipalertinib in Patients With Epidermal Growth Factor Receptor Exon 20 Insertion-Positive Non–Small Cell Lung Cancer Previously Treated With Platinum-
Journal of Clinical Oncology
2025-08-04
Surgical and blood-based minimal residual disease in patients with ovarian cancer after frontline therapy: Clinical outcomes and translational opportu
Clinical Cancer Research
2025-08-05
Phase II (Alliance A091802) Randomized Trial of Avelumab Plus Cetuximab Versus Avelumab Alone in Advanced Cutaneous Squamous Cell Carcinoma
Journal of Clinical Oncology
2025-08-04
0.085397005081177
